SEC Company Response from RVL Pharmaceuticals plc (RVLPQ) (CIK 0001739426) — Feb 10, 2020
RVL Pharmaceuticals plc (RVLPQ) (CIK 0001739426)
Date: Feb. 10, 2020 · CIK: 0001739426 · Accession: 0001104659-20-012915
AI Filing Summary & Sentiment
File numbers found in text: 333-236193
Letter
OSMOTICA PHARMACEUTICALS PLC
400 Crossing Boulevard
Bridgewater, New Jersey 08807
February 10, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Osmotica Pharmaceuticals plc
Registration Statement on Form S-3 (File No. 333-236193)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Osmotica Pharmaceuticals plc, an Irish public limited company (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 12, 2020, or as soon as possible thereafter. The Company hereby authorizes Craig Marcus or William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please notify Craig Marcus of Ropes & Gray LLP, counsel to the Company, at (617) 951-7802 as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
OSMOTICA PHARMACEUTICALS PLC
Show Raw Text
CORRESP 1 filename1.htm OSMOTICA PHARMACEUTICALS PLC 400 Crossing Boulevard Bridgewater, New Jersey 08807 February 10, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Osmotica Pharmaceuticals plc Registration Statement on Form S-3 (File No. 333-236193) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Osmotica Pharmaceuticals plc, an Irish public limited company (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 12, 2020, or as soon as possible thereafter. The Company hereby authorizes Craig Marcus or William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please notify Craig Marcus of Ropes & Gray LLP, counsel to the Company, at (617) 951-7802 as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, OSMOTICA PHARMACEUTICALS PLC By: /s/ Brian Markison Brian Markison Chief Executive Officer and Chairman of the Board of Directors [Signature Page to Acceleration Request Letter] 2